Your browser doesn't support javascript.
loading
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study.
Hsu, Lewis L; Sarnaik, Sharada; Williams, Suzan; Amilon, Carl; Wissmar, Jenny; Berggren, Anders.
Afiliação
  • Hsu LL; Children's Hospital University of Illinois, Chicago, Illinois.
  • Sarnaik S; Children's Hospital of Michigan, Detroit, Michigan.
  • Williams S; Hospital for Sick Children, Toronto, Ontario, Canada.
  • Amilon C; Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Wissmar J; Global Medicine Development, AstraZeneca, Gothenburg, Sweden.
  • Berggren A; Global Medicine Development, AstraZeneca, Gothenburg, Sweden.
Am J Hematol ; 93(12): 1493-1500, 2018 12.
Article em En | MEDLINE | ID: mdl-30187935
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticagrelor / Anemia Falciforme Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticagrelor / Anemia Falciforme Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article